Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02438399 | ACT BORTEZOMIB | TEVA CANADA LIMITED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02456176 | BORTEZOMIB | APOTEX INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02452456 | BORTEZOMIB FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02547287 | BORTEZOMIB FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02467003 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02467011 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02480255 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Approved |
| 02480263 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3 MG | Approved |
| 02485257 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02493306 | BORTEZOMIB FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02541777 | BORTEZOMIB FOR INJECTION | GENERIC MEDICAL PARTNERS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02497433 | BORTEZOMIB FOR INJECTION | AURO PHARMA INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02536773 | BORTEZOMIB FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02423405 | BORTEZOMIB FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02550075 | BORTEZOMIB INJECTION | DR REDDY'S LABORATORIES LTD | Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02521814 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Approved |
| 02499061 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02511932 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02262452 | VELCADE | JANSSEN INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02494930 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Cancelled Post Market |
| 02494922 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Cancelled Pre Market |
| 02453487 | BORTEZOMIB FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Cancelled Pre Market |
| 02503352 | BORTEZOMIB FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Cancelled Post Market |